0

Inflammatory Bowel Disease Collection
 1-20 of 119 Articles
Ideas and Opinions |  1 April 2014
Why We Should Care About What You Get for “Only $99” From a Personal Genomic Service$99 Personal Genomic Service
Michael F. Murray, MD
Ann Intern Med. 2014;160(7):507-508. doi:10.7326/M13-2804
Original Research |  6 March 2012
Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis: A Cohort Study
Ashwin N. Ananthakrishnan, MD, MPH; Leslie M. Higuchi, MD, MPH; Edward S. Huang, MD, MPH; et al.
Ann Intern Med. 2012;156(5):350-359. doi:10.7326/0003-4819-156-5-201203060-00007
Articles |  6 November 2007
Phosphatidylcholine for Steroid-Refractory Chronic Ulcerative Colitis: A Randomized Trial
Wolfgang Stremmel, MD; Robert Ehehalt, MD; Frank Autschbach, MD; et al.
Ann Intern Med. 2007;147(9):603-610. doi:10.7326/0003-4819-147-9-200711060-00004
Articles |  19 June 2007 FREE
Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab: A Randomized Trial
William J. Sandborn, MD; Paul Rutgeerts, MD, PhD; Robert Enns, MD; et al.
Ann Intern Med. 2007;146(12):829-838. doi:10.7326/0003-4819-146-12-200706190-00159
Editorials |  19 June 2007 FREE
GAIN for Loss: Adalimumab for Infliximab-Refractory Crohn Disease
Peter Mannon, MD
Ann Intern Med. 2007;146(12):888-890. doi:10.7326/0003-4819-146-12-200706190-00011
Reviews |  20 December 2005
New Concepts in the Pathophysiology of Inflammatory Bowel Disease
Giorgos Bamias, MD; Mark R. Nyce, MD; Sarah A. De La Rue, PhD; et al.
Ann Intern Med. 2005;143(12):895-904. doi:10.7326/0003-4819-143-12-200512200-00007
Therapeutics |  May/Jun 2002
Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease
Gurinder Luthra, MD; P. Jay Pasricha, MD
Ann Intern Med. 2002;136(3):92. doi:10.7326/ACPJC-2002-136-3-092
Brief Communications |  15 January 2002
Reporting on Statistical Methods To Adjust for Confounding: A Cross-Sectional Survey
Marcus Müllner, MD; Hugh Matthews, BSc, MBBS; Douglas G. Altman, DSc
Ann Intern Med. 2002;136(2):122-126. doi:10.7326/0003-4819-136-2-200201150-00009
Reviews |  20 November 2001
Diagnosis and Treatment of Perianal Fistulas in Crohn Disease
David A. Schwartz, MD; John H. Pemberton, MD; William J. Sandborn, MD
Ann Intern Med. 2001;135(10):906-918. doi:10.7326/0003-4819-135-10-200111200-00011
Reviews |  21 August 2001
Migration of T Cells in Vivo: Molecular Mechanisms and Clinical Implications
Jürgen Westermann, MD; Britta Engelhardt, MD; Jörg C. Hoffmann, MD
Ann Intern Med. 2001;135(4):279-295. doi:10.7326/0003-4819-135-4-200108210-00013
Academia and the Profession |  19 June 2001
Methodologic Pitfalls in the Determination of Genetic Anticipation: The Case of Crohn Disease
Michael F. Picco, MD, PhD; Steven Goodman, MD, PhD; James Reed, PhD; et al.
Ann Intern Med. 2001;134(12):1124-1129. doi:10.7326/0003-4819-134-12-200106190-00013
Articles |  16 January 2001
Ursodiol Use Is Associated with Lower Prevalence of Colonic Neoplasia in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis
Bruce Y. Tung, MD; Mary J. Emond, PhD; Rodger C. Haggitt, MD; et al.
Ann Intern Med. 2001;134(2):89-95. doi:10.7326/0003-4819-134-2-200101160-00008
Editorials |  16 January 2001 FREE
Chemoprevention in Ulcerative Colitis: Narrowing the Gap between Clinical Practice and Research
Ernest T. Hawk, MD, MPH; Jaye L. Viner, MD, MA
Ann Intern Med. 2001;134(2):158-160. doi:10.7326/0003-4819-134-2-200101160-00017
Brief Communications |  21 November 2000
The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study
Charles N. Bernstein, MD; James F. Blanchard, MD, PhD; William Leslie, MD; et al.
Ann Intern Med. 2000;133(10):795-799. doi:10.7326/0003-4819-133-10-200011210-00012
Brief Communications |  15 May 1997
Intravenous Iron and Erythropoietin for Anemia Associated with Crohn Disease: A Randomized, Controlled Trial
Christoph Gasche, MD; Clemens Dejaco, MD; Thomas Waldhoer, PhD; et al.
Ann Intern Med. 1997;126(10):782-787. doi:10.7326/0003-4819-126-10-199705150-00006
Articles |  1 March 1997
Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial
William J. Sandborn, MD; William J. Tremaine, MD; Kenneth P. Offord, MS; et al.
Ann Intern Med. 1997;126(5):364-371. doi:10.7326/0003-4819-126-5-199703010-00004
Articles |  15 January 1996
An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis: A Randomized, Placebo-Controlled Trial
Stephen B. Hanauer, MD; Charles A. Sninsky, MD; Malcom Robinson, MD; et al.
Ann Intern Med. 1996;124(2):204-211. doi:10.7326/0003-4819-124-2-199601150-00003
Reviews |  15 July 1995
Azathioprine and 6-Mercaptopurine in Crohn Disease: A Meta-Analysis
David C. Pearson; Gary R. May; Gordon H. Fick; et al.
Ann Intern Med. 1995;123(2):132-142. doi:10.7326/0003-4819-123-2-199507150-00009
Reviews |  1 November 1994
The Role of Leukotrienes in Inflammation
William R. Henderson, MD
Ann Intern Med. 1994;121(9):684-697. doi:10.7326/0003-4819-121-9-199411010-00010
Brief Reports |  15 April 1993
Symptomatic Exacerbation of Crohn Disease after Treatment with High-Dose Interleukin-2
Joseph A. Sparano, MD; Lawrence J. Brandt, MD; Janice P. Dutcher, MD; et al.
Ann Intern Med. 1993;118(8):617-618. doi:10.7326/0003-4819-118-8-199304150-00007
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)